CareDx Inc reports results for the quarter ended in March - Earnings Summary

CareDx

10/05/2024 24:05

* CareDx Inc  CDNA.OQ  reported a quarterly adjusted loss
of 3
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -11
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 21 cents per share. Wall Street expected
results to range from -28 cents to -17 cents per share.
    * Revenue fell 6.7% to $72.05 million from a year ago;
analysts
expected $63.14 million. 
    * CareDx Inc's reported EPS for the quarter was a loss of 32
cents​.
    * The company reported a quarterly loss of $16.66 million.
    * CareDx Inc shares had fallen by 3.9% this quarter and
lost 15.2%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for CareDx Inc is
$13.00 
This summary was machine generated from LSEG data May 9 at 11:05
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.21          -0.03          Beat
 Dec. 31 2023      -0.27          -0.17          Beat
 Sep. 30 2023      -0.40          -0.18          Beat
 Jun. 30 2023      -0.31          -0.18          Beat